Vidiac ScoreNCT05697731
Evaluation of Vidiac Scores of Obese and Non-obese Patients Intubated by Videolaryngoscopy
An observational study of Vidiac Score and Videolaryngoscopy, run by Ankara City Hospital Bilkent at 1 site in Turkey (Türkiye).
Trial summary
The aim of the study was to observe the vidiac score values of only patients with obesity as a risk factor for difficult intubation. Secondly, it was aimed to evaluate the number of intubation attempts and intubation time, vidiac scores between non-obese and obese patients and to reveal the differences, if any. Read more about this study
- Who is it for?
- Ages 18 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Vidiac Score, Videolaryngoscopy, Obesity
- What is being tested?
- Vidiac Score
- How many people
- 82 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- Feb 2023to Sep 2023
- How long will I take part?
- 7 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: patients to be operated under general anesthesia and endotracheal intubation
Who may be able to join
- All patients to be operated under general anesthesia and endotracheal intubation
Who cannot join
- under 18 years old
- The patient's refusal
- Difficult airway story before
- Congenital or previous airway anatomical disorder
- Patients who have undergone airway surgery
- Patients with a mass in the head and neck region
Trial locations and contacts
1 site in 1 country.
About this study
The aim of the study was to observe the vidiac score values of only patients with obesity as a risk factor for difficult intubation. Secondly, it was aimed to evaluate the number of intubation attempts and intubation time, vidiac scores between non-obese and obese patients and to reveal the differences, if any.
- Conditions
- Vidiac Score, Videolaryngoscopy, Obesity
- Being tested
- Vidiac Score
- Medical subject headings
- Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Vidiac ScoreDiagnostic test
Vidiac score is a scoring system created according to the visibility of laryngeal structures under videolarnyngoscopy in patients with expected difficult intubation.
| Study group | Role | What they receive |
|---|---|---|
| obese | Vidiac score Mallampati score upper lip bite test Thyromental distance Mandible ramus length Mouth opening distance Receives: Diagnostic Test: Vidiac Score | |
| non-obese | Vidiac score Mallampati score upper lip bite test Thyromental distance Mandible ramus length Mouth opening distance Receives: Diagnostic Test: Vidiac Score |
What is being measured
The primary outcome is the main question the study is designed to answer.
vidiac score
Vidiac score is a scoring system created according to the visibility of laryngeal structures under videoingoscopy in patients with expected difficult intubation.
Measured: during entubation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jan 2023
- Study startFeb 2023 (estimated)
- Primary completionApr 2023 (estimated)
- Study completionSep 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Vidiac ScoreStudies of the same condition, open and under way.
- More trials run by Ankara City Hospital BilkentThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 82 participants (estimated)
- Target duration
- 7 Months
Sponsor and investigators
- Lead sponsor
- Ankara City Hospital Bilkent
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, aysun postaci, Ankara City Hospital Bilkent
- Investigators
- Aysun Postacı, Assoc. Prof, Principal investigator, Ankara City Hospital Bilkent
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05697731
- Sponsor's protocol ID
- E2-22-2939
- Status last verified
- Jan 2023
- First submitted
- 15 Jan 2023
- Last updated
- 26 Jan 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 26 Jan 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Vidiac Scores of Obese and Non-obese Patients Intubated by Videolaryngoscopy
- ClinicalTrials.gov ID
- NCT05697731
- Acronym / sponsor ID
- E2-22-2939
- Conditions
- Vidiac Score, Videolaryngoscopy, Obesity
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 82 participants (estimated)
- Lead sponsor
- Ankara City Hospital BilkentUniversity, hospital or other
- Study start
- Feb 2023 (estimated)
- Primary completion
- Apr 2023 (estimated)
- Study completion
- Sep 2023 (estimated)
- First posted
- 26 Jan 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study was to observe the vidiac score values of only patients with obesity as a risk factor for difficult intubation. Secondly, it was aimed to evaluate the number of intubation attempts and intubation time, vidiac scores between non-obese and obese patients and to reveal the differences, if any.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 7 Months
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| obese | – | Diagnostic Test: Vidiac ScoreVidiac score Mallampati score upper lip bite test Thyromental distance Mandible ramus length Mouth opening distance |
| non-obese | – | Diagnostic Test: Vidiac ScoreVidiac score Mallampati score upper lip bite test Thyromental distance Mandible ramus length Mouth opening distance |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- patients to be operated under general anesthesia and endotracheal intubation
Key inclusion criteria (1 listed)
- All patients to be operated under general anesthesia and endotracheal intubation
Key exclusion criteria (6 listed)
- under 18 years old
- The patient's refusal
- Difficult airway story before
- Congenital or previous airway anatomical disorder
- Patients who have undergone airway surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Vidiac ScoreVidiac score is a scoring system created according to the visibility of laryngeal structures under videolarnyngoscopy in patients with expected difficult intubation. | Diagnostic test | non-obese, obese |
Primary outcome
vidiac score
Time frame: during entubation
Vidiac score is a scoring system created according to the visibility of laryngeal structures under videoingoscopy in patients with expected difficult intubation.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jan 2023.
- Individual participant dataSharing planned: Undecided
Related trials for Vidiac Score
Not yet recruitingObservational study
Ultrasonographic Airway Assessment and VIDIAC Score
Difficult Airway, Difficult Intubation
RecruitingObservational study
BRI, BMI, and VIDAC Score Relationship in Obese Patients
Vidiac Score
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Aysun Postacı, Assoc. Prof principal investigator
Ankara City Hospital Bilkent
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Vidiac Score and Videolaryngoscopy, run by Ankara City Hospital Bilkent at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 26 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact betül güven aytaç, MD (+905073578351, drbguven@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
vidiac score (time frame: during entubation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2023.